Metformin Plus Irinotecan in Patients With Refractory Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Metformin Plus Irinotecan in Patients With Refractory Colorectal Cancer: A Phase 2 Clinical Trial
Br. J. Cancer 2021 Jan 04;[EPub Ahead of Print], AC Bragagnoli, RLC Araujo, MW Ferraz, LV Dos Santos, KC Abdalla, F Comar, FA Santos, MA Oliveira, JBC Carvalheira, FM Cárcano, JP da Silveira Nogueira LimaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.